AMGEN Inc
NASDAQ: AMGN
$307.81
+$18.79 (+6.5%)
Closing Price on February 5, 2025
AMGN Articles
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Published:
Last Updated:
One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is the large cap biotechs.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday include Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor and Wal-Mart.
Published:
Last Updated:
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
Amgen Inc. (NASDAQ: AMGN) reported its fourth-quarter financial results after the markets closed on Thursday. This biotech giant posted $2.89 in earnings per share (EPS) and $5.97 billion in revenue,...
Published:
Last Updated:
Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems the animal spirits powering this rally might not be as positive as they once...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday include Amgen, Apple, Corning, Mobileye, Under Armour and Electronic Arts.
Published:
Last Updated:
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks to buy that have a large enough market cap to provide some safety.
Published:
Last Updated:
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Published:
Last Updated:
Tthe top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, American Express, American Water Works, Celgene and Square.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.